Yangyi Nie
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yangyi Nie has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Wei Zhang
Centre for Translational Medicine Research & Development, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, China
3 shared publications - Yuxiao Lai
Centre for Translational Medicine Research and Development, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China
3 shared publications - Cairong Li
Centre for Translational Medicine Research and Development, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, China
2 shared publications - Long Li
Centre for Translational Medicine Research & Development, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, China
2 shared publications - Yuanchi Zhang
Centre for Translational Medicine Research and Development, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, China
2 shared publications - Yuyang Zhang
National Innovation Center for Advanced Medical Devices, Shenzhen 518131, China
2 shared publications
Latest Publications
- Open Access
- 21 September 2026
- Published by MDPI AG in Bioengineering
- Vol. 13 (9) , 1093
Multifunctional Roles of Magnesium Ions in Modulating Bone Regeneration-Related Cells
Magnesium ions (Mg2+) play pivotal roles in bone regeneration by regulating the biological functions of multiple bone repair-related cells. However, the effective concentration ranges and optimal concentration of Mg2+ for different cell types remain incompletely defined, which limits the precise design of Mg-containing biomaterials with controllable ion release for repairing of bone defects. In this study, the concentration-dependent effects of Mg2+ on the biological functions of bone regeneration-related cells were systematically investigated. Human bone marrow mesenchymal stem cells (hBMSCs), human umbilical vein endothelial cells (HUVECs), rat Schwann cells (RSCs), and RAW264.7 macrophage were selected to evaluate the effective concentration of Mg2+ for promoting osteogenesis, angiogenesis, neuroregulation, and immunomodulation, respectively. The results demonstrated that Mg2+ concentrations ranging from to 16 mM, particularly 8 mM, significantly upregulated the expression of M2 macrophage-related markers, thereby promoting the polarization of RAW264.7 macrophages toward the anti-inflammatory M2 phenotype. Moreover, Mg2+ concentrations between 2 and 8 mM effectively enhanced the osteogenic activity of hBMSCs, the angiogenic activity of HUVECs, and the neuroregulatory function of RSCs, as confirmed by immunofluorescence staining and quantitative PCR analysis of osteogenic, angiogenic, and neuroregulation-related marker expression. These findings provide a comprehensive understanding of the concentration-dependent biological effects of Mg2+ on bone regeneration-related cells and establish a theoretical basis for the rational design of next-generation Mg2+-releasing biomaterials with precise biological regulation.
- 21 September 2026
- Published by MDPI AG in Bioengineering
- Vol. 13 (9) , 1093
Open AccessMultifunctional Roles of Magnesium Ions in Modulating Bone Regeneration-Related Cells
Magnesium ions (Mg2+) play pivotal roles in bone regeneration by regulating the biological functions of multiple bone repair-related cells. However, the effective concentration ranges and optimal concentration of Mg2+ for different cell types remain incompletely defined, which limits the precise design of Mg-containing biomaterials with controllable ion release for repairing of bone defects. In this study, the concentration-dependent effects of Mg2+ on the biological functions of bone regeneration-related cells were systematically investigated. Human bone marrow mesenchymal stem cells (hBMSCs), human umbilical vein endothelial cells (HUVECs), rat Schwann cells (RSCs), and RAW264.7 macrophage were selected to evaluate the effective concentration of Mg2+ for promoting osteogenesis, angiogenesis, neuroregulation, and immunomodulation, respectively. The results demonstrated that Mg2+ concentrations ranging from to 16 mM, particularly 8 mM, significantly upregulated the expression of M2 macrophage-related markers, thereby promoting the polarization of RAW264.7 macrophages toward the anti-inflammatory M2 phenotype. Moreover, Mg2+ concentrations between 2 and 8 mM effectively enhanced the osteogenic activity of hBMSCs, the angiogenic activity of HUVECs, and the neuroregulatory function of RSCs, as confirmed by immunofluorescence staining and quantitative PCR analysis of osteogenic, angiogenic, and neuroregulation-related marker expression. These findings provide a comprehensive understanding of the concentration-dependent biological effects of Mg2+ on bone regeneration-related cells and establish a theoretical basis for the rational design of next-generation Mg2+-releasing biomaterials with precise biological regulation.
- Open Access
Design and Fabrication of Low-Temperature 3D-Printed Bioactive Polyurethane/MnO2 Scaffolds for Bone Repair
Bone defect repair presents a significant clinical challenge, especially for critical-sized defects, due to the limitation of conventional 3D-printed scaffolds to provide simultaneous mechanical support and bioactivity. Herein, this study developed a bioactive composite scaffold through a low-temperature rapid prototyping (LT-RP) 3D printing technology. The scaffold comprises a polyurethane (PU) matrix enhanced with bioactive manganese dioxide (MnO2) nanoparticles, combining structural integrity with versatile bioactivity for bone repair. By incorporating 2, 6-pyridinedimethanol (PDM) into the PU molecular network, a coordination system is formed, enabling homogeneous distribution and structural integration of MnO2 nanoparticles. As designed, the bioactive scaffolds are fabricated through LT-RP 3D printing technology with a regular porous architecture for improving cell growth. With 10 wt% MnO2, the scaffolds (PPM10) have optimal comprehensive properties, with a modulus of ~14.1 MPa, improved thermal stability, good cytocompatibility, and enhanced osteogenic differentiation. Furthermore, in vitro degradation tests revealed the responsive release of Mn2+ from the PPM10 scaffolds in a glutathione-rich microenvironment. This functionality indicates the potential of the scaffolds to modify the tumor microenvironment for ultimate bone regeneration after bone tumor surgery.
Open AccessDesign and Fabrication of Low-Temperature 3D-Printed Bioactive Polyurethane/MnO2 Scaffolds for Bone Repair
Bone defect repair presents a significant clinical challenge, especially for critical-sized defects, due to the limitation of conventional 3D-printed scaffolds to provide simultaneous mechanical support and bioactivity. Herein, this study developed a bioactive composite scaffold through a low-temperature rapid prototyping (LT-RP) 3D printing technology. The scaffold comprises a polyurethane (PU) matrix enhanced with bioactive manganese dioxide (MnO2) nanoparticles, combining structural integrity with versatile bioactivity for bone repair. By incorporating 2, 6-pyridinedimethanol (PDM) into the PU molecular network, a coordination system is formed, enabling homogeneous distribution and structural integration of MnO2 nanoparticles. As designed, the bioactive scaffolds are fabricated through LT-RP 3D printing technology with a regular porous architecture for improving cell growth. With 10 wt% MnO2, the scaffolds (PPM10) have optimal comprehensive properties, with a modulus of ~14.1 MPa, improved thermal stability, good cytocompatibility, and enhanced osteogenic differentiation. Furthermore, in vitro degradation tests revealed the responsive release of Mn2+ from the PPM10 scaffolds in a glutathione-rich microenvironment. This functionality indicates the potential of the scaffolds to modify the tumor microenvironment for ultimate bone regeneration after bone tumor surgery.
- Open Access
Exosomes Derived from Mg-Preconditioned Bone Mesenchymal Stem Cells Promote Angiogenesis and Osteogenesis for Osteonecrosis Treatment
Steroid-induced osteonecrosis of the femoral head (SONFH) is a common and refractory orthopedic disorder, often resulting from prolonged or high-dose glucocorticoid use that impairs bone repair and vascularization. The critical impact of exosomes derived from bone mesenchymal stem cells (BMSCs) in bone regeneration has drawn increasing attention. In this study, we developed a novel type of exosomes derived from Magnesium-preconditioned BMSCs (Mg-Exos) and evaluated their therapeutic potential. In vitro experiments demonstrated that Mg-Exos effectively counteracted Dex-induced impairment in the angiogenic function of human umbilical vein endothelial cells (HUVECs) and the osteogenic differentiation of BMSCs. These findings highlight the promise of Mg-Exos as a potential cell-free therapeutic strategy for SONFH, acting through the concurrent enhancement of vascularization and bone formation. Consequently, this work lays a solid foundation for the future application of Mg-Exos in treating SONFH.
Open AccessExosomes Derived from Mg-Preconditioned Bone Mesenchymal Stem Cells Promote Angiogenesis and Osteogenesis for Osteonecrosis Treatment
Steroid-induced osteonecrosis of the femoral head (SONFH) is a common and refractory orthopedic disorder, often resulting from prolonged or high-dose glucocorticoid use that impairs bone repair and vascularization. The critical impact of exosomes derived from bone mesenchymal stem cells (BMSCs) in bone regeneration has drawn increasing attention. In this study, we developed a novel type of exosomes derived from Magnesium-preconditioned BMSCs (Mg-Exos) and evaluated their therapeutic potential. In vitro experiments demonstrated that Mg-Exos effectively counteracted Dex-induced impairment in the angiogenic function of human umbilical vein endothelial cells (HUVECs) and the osteogenic differentiation of BMSCs. These findings highlight the promise of Mg-Exos as a potential cell-free therapeutic strategy for SONFH, acting through the concurrent enhancement of vascularization and bone formation. Consequently, this work lays a solid foundation for the future application of Mg-Exos in treating SONFH.